The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
Open accessAbstract
A novel human coronavirus (HCoV-EMC) was recently identified in the Middle East as the causative agent of a severe acute respiratory syndrome (SARS) resembling the illness caused by SARS coronavirus (SARS-CoV). Although derived from the CoV family, the two viruses are genetically distinct and do not use the same receptor. Here, we investigated whether HCoV-EMC and SARS-CoV induce similar or distinct host responses after infection of a human lung epithelial cell line. HCoV-EMC was able to replicate as efficiently as SARS-CoV in Calu-3 cells and similarly induced minimal transcriptomic changes before 12 h postinfection. Later in infection, HCoV-EMC induced a massive dysregulation of the host transcriptome, to a much greater extent than SARS-CoV. Both viruses induced a similar activation of pattern recognition receptors and the interleukin 17 (IL-17) pathway, but HCoV-EMC specifically down-regulated the expression of several genes within the antigen presentation pathway, including both type I and II major histocompatibility complex (MHC) genes. This could have an important impact on the ability of the host to mount an adaptive host response. A unique set of 207 genes was dysregulated early and permanently throughout infection with HCoV-EMC, and was used in a computational screen to predict potential antiviral compounds, including kinase inhibitors and glucocorticoids. Overall, HCoV-EMC and SARS-CoV elicit distinct host gene expression responses, which might impact in vivo pathogenesis and could orient therapeutic strategies against that emergent virus. IMPORTANCE Identification of a novel coronavirus causing fatal respiratory infection in humans raises concerns about a possible widespread outbreak of severe respiratory infection similar to the one caused by SARS-CoV. Using a human lung epithelial cell line and global transcriptomic profiling, we identified differences in the host response between HCoV-EMC and SARS-CoV. This enables rapid assessment of viral properties and the ability to anticipate possible differences in human clinical responses to HCoV-EMC and SARS-CoV. We used this information to predict potential effective drugs against HCoV-EMC, a method that could be more generally used to identify candidate therapeutics in future disease outbreaks. These data will help to generate hypotheses and make rapid advancements in characterizing this new virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Primer3 on the WWW for General Users and for Biologist Programmers
Rozen, S., & Skaletsky, H. (2003) · Bioinformatics Methods and Protocols · doi:10.1385/1-59259-192-2:365 · Cited by 15,013
limma: Linear Models for Microarray Data
Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Bioinformatics and Computational Biology Solutions Using R and Bioconductor
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0 · Cited by 3,289
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Self-citationThe Severe Acute Respiratory Syndrome
Peiris, J. S. M., Yuen, K. Y., Osterhaus, A. D. M. E., & Stöhr, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra032498 · Cited by 1,346
SARS: systematic review of treatment effects
Stockman, L. J., Bellamy, R., & Garner, P. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030343 · Cited by 1,217
BioMart – biological queries made easy
Smedley, D., Haider, S., Ballester, B., Holland, R., London, D., Thorisson, G., & Kasprzyk, A. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-22 · Cited by 1,111
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945
van Boheemen, S., de Graaf, M., Lauber, C., Bestebroer, T. M., Raj, V. S., Zaki, A. M., Osterhaus, A. D. M. E., Haagmans, B. L., Gorbalenya, A. E., Snijder, E. J., et al. (2012) · mBio · doi:10.1128/mbio.00473-12 · Cited by 914
Sirota, M., Dudley, J. T., Kim, J., Chiang, A. P., Morgan, A. A., Sweet-Cordero, A., Sage, J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001318 · Cited by 799
Development of PI3K inhibitors: lessons learned from early clinical trials
Rodon, J., Dienstmann, R., Serra, V., & Tabernero, J. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.10 · Cited by 766
The MHC class I antigen presentation pathway: strategies for viral immune evasion
Hewitt, E. W. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01738.x · Cited by 487
Bermingham, A., Chand, M. A., Brown, C. S., Aarons, E., Tong, C., Langrish, C., Hoschler, K., Brown, K., Galiano, M., Myers, R., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.40.20290-en · Cited by 468
Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits
Griffin, T. A., Nandi, D., Cruz, M., Fehling, H. J., Kaer, L. V., Monaco, J. J., & Colbert, R. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.97 · Cited by 444
MHC class I antigen presentation: learning from viral evasion strategies
Hansen, T. H., & Bouvier, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2575 · Cited by 426
Pfefferle, S., Schöpf, J., Kögl, M., Friedel, C. C., Müller, M. A., Carbajo-Lozoya, J., Stellberger, T., von Dall’Armi, E., Herzog, P., Kallies, S., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002331 · Cited by 415
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
Yount, B., Curtis, K. M., Fritz, E. A., Hensley, L. E., Jahrling, P. B., Prentice, E., Denison, M. R., Geisbert, T. W., & Baric, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735582100 · Cited by 376
Self-citationCritical Role of IL-17RA in Immunopathology of Influenza Infection
Crowe, C. R., Chen, K., Pociask, D. A., Alcorn, J. F., Krivich, C., Enelow, R. I., Ross, T. M., Witztum, J. L., & Kolls, J. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900995 · Cited by 349
Johnson, R. A., Wang, X., Ma, X.-L., Huong, S.-M., & Huang, E.-S. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6022-6032.2001 · Cited by 228
Müller, M. A., Raj, V. S., Muth, D., Meyer, B., Kallies, S., Smits, S. L., Wollny, R., Bestebroer, T. M., Specht, S., Suliman, T., et al. (2012) · mBio · doi:10.1128/mbio.00515-12 · Cited by 209
Kindler, E., Jónsdóttir, H. R., Muth, D., Hamming, O. J., Hartmann, R., Rodriguez, R., Geffers, R., Fouchier, R. A. M., Drosten, C., Müller, M. A., et al. (2013) · mBio · doi:10.1128/mbio.00611-12 · Cited by 202
Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
Carbajo-Lozoya, J., Müller, M. A., Kallies, S., Thiel, V., Drosten, C., & von Brunn, A. (2012) · Virus Research · doi:10.1016/j.virusres.2012.02.002 · Cited by 201
Yoshikawa, T., Hill, T. E., Yoshikawa, N., Popov, V. L., Galindo, C. L., Garner, H. R., Peters, C. J., & Tseng, C.-T. (. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008729 · Cited by 190
Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation
Shin, Y.-K., Liu, Q., Tikoo, S. K., Babiuk, L. A., & Zhou, Y. (2007) · Journal of General Virology · doi:10.1099/vir.0.82483-0 · Cited by 161
Sims, A. C., Tilton, S. C., Menachery, V. D., Gralinski, L. E., Schäfer, A., Matzke, M. M., Webb-Robertson, B.-J. M., Chang, J., Luna, M. L., Long, C. E., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02520-12 · Cited by 158
Self-citationSoares, J. A. P., Leite, F. G. G., Andrade, L. G., Torres, A. A., Sousa, L. P., Barcelos, L. S., Teixeira, M. M., Ferreira, P. C. P., Kroon, E. G., Souto-Padrón, T. C. B. S., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00245-09 · Cited by 143
Regulation of epithelial immunity by IL-17 family cytokines
Pappu, R., Rutz, S., & Ouyang, W. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.02.008 · Cited by 142
Cunningham, A. C., ZHANG, J. ‐., Moy, J. V., Ali, S., & Kirby, J. A. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.d01-2249.x · Cited by 117
Emerging Role of Ubiquitination in Antiviral RIG-I Signaling
Maelfait, J., & Beyaert, R. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05012-11 · Cited by 111
Viral inhibition of MHC class II antigen presentation
Hegde, N. R. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00099-1 · Cited by 101
Kumar, S., Orsini, M. J., Lee, J. C., McDonnell, P., Debouck, C. M., & Young, P. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30864 · Cited by 100
Ehrhardt, C., Rückle, A., Hrincius, E. R., Haasbach, E., Anhlan, D., Ahmann, K., Banning, C., Reiling, S. J., Kühn, J., Strobl, S., et al. (2013) · Cellular Microbiology · doi:10.1111/cmi.12108 · Cited by 94
Millan, D. S., Bunnage, M. E., Burrows, J. L., Butcher, K. J., Dodd, P. G., Evans, T. J., Fairman, D. A., Hughes, S. J., Kilty, I., Lemaitre, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200677b · Cited by 94
Host Regulatory Network Response to Infection with Highly Pathogenic H5N1 Avian Influenza Virus
Li, C., Bankhead, A., Eisfeld, A. J., Hatta, Y., Jeng, S., Chang, J. H., Aicher, L. D., Proll, S. C., Ellis-Connell, A. L., Law, G. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05792-11 · Cited by 93
Self-citationIL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells
Ryzhakov, G., Lai, C., Blazek, K. D., To, K.-W., Hussell, T., & Udalova, I. A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100917 · Cited by 91
Roles of p38 MAPK and JNK in TGF-β1-induced Human Alveolar Epithelial to Mesenchymal Transition
Chen, H., Zhou, X., Shi, Y., & Yang, J. (2013) · Archives of Medical Research · doi:10.1016/j.arcmed.2013.01.004 · Cited by 91
Effect of p38 Mitogen-Activated Protein Kinase on the Replication of Encephalomyocarditis Virus
Hirasawa, K., Kim, A., Han, H.-S., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5649-5656.2003 · Cited by 81
Mitogen activated protein kinase inhibitors: where are we now and where are we going?
Sweeney, S. E., & Firestein, G. S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058388 · Cited by 79
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Josset, L., Textoris, J., Loriod, B., Ferraris, O., Moulés, V., Lina, B., Nguyen, C., Diaz, J., & Rosa‐Calatrava, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013169 · Cited by 77
Self-citationLudwig, S. (2011) · Biological Chemistry · doi:10.1515/bc.2011.121 · Cited by 72
Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle
Munoz, L., Ramsay, E. E., Manetsch, M., Ge, Q., Peifer, C., Laufer, S., & Ammit, A. J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.037 · Cited by 34
Novel HIV-1 therapeutics through targeting altered host cell pathways
Coley, W., Kehn‐Hall, K., Duyne, R. V., & Kashanchi, F. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903257781 · Cited by 32
Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus
Perlman, S. M., & Zhao, J. (2013) · mBio · doi:10.1128/mbio.00002-13 · Cited by 22
Terajima, M., Inoue, T., Magari, K., Yamazaki, H., Higashi, Y., & Mizuhara, H. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.021 · Cited by 17
Cited by
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Costela-Ruiz, V. J., Illescas-Montes, R., Puerta-Puerta, J. M., Ruiz, C., & Melguizo-Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,121
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,114
Metadata
- Authors
- Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G.
- Venue
- mBio
- Publisher
- American Society for Microbiology
- Published
- 2013-07
- Volume
- 4
- Issue
- 3
- Pages
- e00165-13
- ISSN
- 2150-7511 (ISSN-L)
- 2161-2129
- OpenAlex
- W2016921919
- Cited by
- 293
- References
- 49
- FWCI
- 17.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.